Author: "Hurwitz MD" / Topic: bevacizumab - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Hurwitz MD"' showing total 6 results

Start Over Author "Hurwitz MD" Topic bevacizumab

6 results on '"Hurwitz MD"'

1. Bevacizumab in Treating Patients With Advanced Solid Tumors

Author: National Cancer Institute (NCI) and Herbert Hurwitz, MD, Associate Professor of Medicine
Published: 2016

2. XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib (XAD)

Author: Bristol-Myers Squibb and Herbert Hurwitz, MD, Associate Professor of Medicine
Published: 2016

3. Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors (CNTO95/Avastin)

Author: Centocor, Inc., Genentech, Inc., and Herbert Hurwitz, MD, Associate Professor of Medicine
Published: 2015

4. Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

Author: National Cancer Institute (NCI) and Herbert Hurwitz, MD, Associate Professor
Published: 2014

5. BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) (BEP)

Author: Novartis, Genentech, Inc., Amgen, and Herbert Hurwitz, MD, Associate Professor of Medicine
Published: 2014

6. Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Author: National Cancer Institute (NCI) and Herbert Hurwitz, MD, Associate Professor of Medicine
Published: 2014

Catalog

Books, media, physical & digital resources

See catalog results